FDA Accepts for Priority Review Merck’s Supplemental New Drug Application for WELIREG (belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) Read more
European Commission Approves Pfizer’s LITFULO for Adolescents and Adults With Severe Alopecia Areata Read more
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission Read more
AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology Read more
Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease Read more
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union Read more
Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases Read more
Roche’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes Read more